Helus Pharma
Develops investigational serotonergic therapies for depression and generalized anxiety disorder.
$12.35
After-hours close+0.19 (+1.56%)
At close$12.16(−8.16%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions —Insiders —
Shares outstanding 61.98M · Float 48.69M · 78.6% free float
Institutions13F
No 13F holders on record.
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.